Review
doi: 10.2174/156720107782151278.
Painting the target around the arrow: two-step prodrug therapies from a carbohydrate chemist's perspective
Affiliations
- PMID: 17979645
- DOI: 10.2174/156720107782151278
Item in Clipboard
Review
Painting the target around the arrow: two-step prodrug therapies from a carbohydrate chemist's perspective
Curr Drug Deliv.
2007 Oct.
Abstract
Selective accumulation of an exogenous enzyme or activating agent at a target cell allows use of prodrugs that will be unmasked only at this site. This can reduce the side effects of chemotherapy and allow more potent drugs to be used in various treatments. Examples of this two-step prodrug therapy include antibody- (ADEPT, ADAPT), genetic- (GDEPT, VDEPT) and macromolecule-based approaches (PDEPT, LEAPT). Carbohydrate chemistry and glycobiology feature in each of these areas and is the focus of this review.
Similar articles
-
Advances in prodrug design.Mini Rev Med Chem. 2005 Oct;5(10):893-914. doi: 10.2174/138955705774329528. Mini Rev Med Chem. 2005. PMID: 16250833 Review.
-
Prodrugs: a challenge for the drug development.Pharmacol Rep. 2013;65(1):1-14. doi: 10.1016/s1734-1140(13)70959-9. Pharmacol Rep. 2013. PMID: 23563019 Review.
-
Targeted enzyme prodrug therapies.Mini Rev Med Chem. 2010 Sep;10(10):887-904. doi: 10.2174/138955710792007196. Mini Rev Med Chem. 2010. PMID: 20560876 Review.
-
Prodrugs for targeted tumor therapies: recent developments in ADEPT, GDEPT and PMT.Curr Pharm Des. 2011;17(32):3527-47. doi: 10.2174/138161211798194459. Curr Pharm Des. 2011. PMID: 22074425 Review.
-
Strategies for enzyme/prodrug cancer therapy.Clin Cancer Res. 2001 Nov;7(11):3314-24. Clin Cancer Res. 2001. PMID: 11705842 Review.
Cited by
-
Enzymatic activation of a matrix metalloproteinase inhibitor.Chem Commun (Camb). 2010 Feb 28;46(8):1241-3. doi: 10.1039/b923302d. Epub 2010 Jan 18. Chem Commun (Camb). 2010. PMID: 20449263 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources